A mouse model of OI type IV (Col1a2+/p.G610C) with a Gly to Cys Col1a2 missense mutation in the triple helix, based on an Old Order Amish OI mutation,5 provides us with an experimental tool for pre‐clinical therapeutic testing. The gene discussed is COL1A2; the disease is osteogenesis imperfecta.